Biopharmaceutical CMO & CRO Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Biopharmaceutical CMO & CRO
1.1 Biopharmaceutical CMO & CRO Market Overview
1.1.1 Biopharmaceutical CMO & CRO Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biopharmaceutical CMO & CRO Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Biopharmaceutical CMO & CRO Market by Type
1.3.1 Mammalian
1.3.2 Non-mammalian
1.4 Biopharmaceutical CMO & CRO Market by End Users/Application
1.4.1 Contract Manufacturing
1.4.2 Contract Research
2 Global Biopharmaceutical CMO & CRO Competition Analysis by Players
2.1 Biopharmaceutical CMO & CRO Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Lonza
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.1.5 Recent Developments
3.2 Boehringer Ingelheim GmbH
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.2.5 Recent Developments
3.3 Rentschler Biotechnologie GmbH
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.3.5 Recent Developments
3.4 Inno Biologics Sdn Bhd
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.4.5 Recent Developments
3.5 JRS Pharma
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.5.5 Recent Developments
3.6 BIOMEVA GmbH
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.6.5 Recent Developments
3.7 ProBioGen
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.7.5 Recent Developments
3.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.8.5 Recent Developments
3.9 TOYOBO CO., LTD
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.9.5 Recent Developments
3.10 Samsung BioLogics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biopharmaceutical CMO & CRO Revenue (Value) (2015-2020)
3.10.5 Recent Developments
3.11 Patheon
3.12 CMC Biologics
3.13 Binex Co., Ltd.
3.14 AbbVie Inc.
3.15 WuXi Biologics
4 Global Biopharmaceutical CMO & CRO Market Size by Type and Application (2015-2020)
4.1 Global Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
4.3 Potential Application of Biopharmaceutical CMO & CRO in Future
4.4 Top Consumer/End Users of Biopharmaceutical CMO & CRO
5 North America Biopharmaceutical CMO & CRO Development Status and Outlook
5.1 North America Biopharmaceutical CMO & CRO Market Size (2015-2020)
5.2 North America Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
6 Europe Biopharmaceutical CMO & CRO Development Status and Outlook
6.1 Europe Biopharmaceutical CMO & CRO Market Size (2015-2020)
6.2 Europe Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
7 China Biopharmaceutical CMO & CRO Development Status and Outlook
7.1 China Biopharmaceutical CMO & CRO Market Size (2015-2020)
7.2 China Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Biopharmaceutical CMO & CRO Development Status and Outlook
8.1 Rest of Asia Pacific Biopharmaceutical CMO & CRO Market Size (2015-2020)
8.2 Rest of Asia Pacific Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Biopharmaceutical CMO & CRO Development Status and Outlook
9.1 Central & South America Biopharmaceutical CMO & CRO Market Size (2015-2020)
9.2 Central & South America Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Biopharmaceutical CMO & CRO Development Status and Outlook
10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2015-2020)
10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2028)
11.1 Global Biopharmaceutical CMO & CRO Market Size (Value) by Regions (2021-2028)
11.1.1 North America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.1.2 Europe Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.1.3 China Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.1.4 Rest of Asia Pacific Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.1.5 Central & South America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.1.6 Middle East & Africa Biopharmaceutical CMO & CRO Revenue and Growth Rate (2021-2028)
11.2 Global Biopharmaceutical CMO & CRO Market Size (Value) by Type (2021-2028)
11.3 Global Biopharmaceutical CMO & CRO Market Size by Application (2021-2028)
12 Biopharmaceutical CMO & CRO Market Dynamics
12.1 Biopharmaceutical CMO & CRO Market Opportunities
12.2 Biopharmaceutical CMO & CRO Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Biopharmaceutical CMO & CRO Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Biopharmaceutical CMO & CRO Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
